Prevest Denpro has confirmed that there are no deviation(s) or variation(s) in respect of utilization of proceeds of Initial Public Offer of the Company for the quarter ended March 31, 2023, as mentioned in the object clause of the offer letter of the issue.
The above information is a part of company’s filings submitted to BSE.